Deepa Sampath Selected Research

ibrutinib

1/2021	Preclinical evaluation of the Hsp90 inhibitor SNX-5422 in ibrutinib resistant CLL.
10/2018	The BTK Inhibitor ARQ 531 Targets Ibrutinib-Resistant CLL and Richter Transformation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Deepa Sampath Research Topics

Disease

21	Neoplasms (Cancer) 03/2024 - 10/2007
18	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 03/2024 - 12/2006
10	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2022 - 03/2006
4	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 11/2013
4	Glioma (Gliomas) 01/2022 - 11/2011
2	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 10/2017
2	Lymphoma (Lymphomas) 10/2019 - 01/2011
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2012 - 04/2009
1	Residual Neoplasm 11/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2022
1	Anemia 01/2021
1	Wounds and Injuries (Trauma) 01/2021
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021
1	Leukemia 12/2019
1	Lewis Lung Carcinoma 12/2018
1	Cachexia 12/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 12/2018
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2011
1	Ataxia Telangiectasia (Louis Bar Syndrome) 04/2007
1	Myeloid Leukemia (Leukemia, Myelocytic) 09/2002

Drug/Important Bio-Agent (IBA)

8	MicroRNAs (MicroRNA)IBA 01/2020 - 10/2007
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2011
6	Agammaglobulinaemia Tyrosine KinaseIBA 03/2024 - 12/2016
4	KPT-9274IBA 01/2022 - 12/2019
4	Histone Deacetylases (Histone Deacetylase)IBA 01/2021 - 11/2011
3	ChromatinIBA 06/2023 - 01/2011
3	fludarabineIBA 07/2011 - 09/2002
2	Molecular Chaperones (Chaperone, Molecular)IBA 01/2022 - 10/2017
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2022 - 01/2021
2	EnzymesIBA 01/2022 - 01/2021
2	(2,4- dihydroxy- 5- isopropylphenyl)- (5- (4- methylpiperazin- 1- ylmethyl)- 1,3- dihydroisoindol- 2- yl)methanoneIBA 01/2022 - 10/2017
2	ibrutinibIBA 01/2021 - 10/2018
2	NucleosidesIBA 01/2019 - 09/2002
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2011 - 12/2006
1	RNA (Ribonucleic Acid)IBA 03/2024
1	Positive Transcriptional Elongation Factor BIBA 01/2023
1	Apoptosis Regulatory ProteinsIBA 11/2022
1	venetoclaxIBA 11/2022
1	AntibodiesIBA 10/2022
1	fms-Like Tyrosine Kinase 3IBA 09/2022
1	Dihydroorotate DehydrogenaseIBA 09/2022
1	gilteritinibIBA 09/2022
1	NAD (NADH)IBA 01/2022
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2022
1	SNX-5422IBA 01/2021
1	Toll-Like Receptor 7IBA 12/2018
1	Caspase 3 (Caspase-3)IBA 12/2018
1	PLX51107IBA 01/2018
1	epidermal growth factor receptor VIIIIBA 10/2017
1	Temozolomide (Temodar)FDA LinkGeneric 10/2017
1	Long Noncoding RNAIBA 04/2017
1	Biomarkers (Surrogate Marker)IBA 04/2017
1	selinexorIBA 12/2016
1	trioctyl phosphine oxide (TOPO)IBA 12/2016
1	sapacitabineIBA 01/2016
1	Histone Deacetylase InhibitorsIBA 01/2016
1	triciribine phosphateIBA 11/2013
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 11/2013
1	SolutionsIBA 06/2012
1	mouse MIRN29 microRNAIBA 02/2012
1	Vorinostat FDA Link 11/2011
1	Cell Cycle ProteinsIBA 11/2011
1	Histones (Histone)IBA 11/2011
1	EndonucleasesIBA 07/2011
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2011
1	Protein Kinases (Protein Kinase)IBA 01/2011
1	UbiquitinIBA 04/2009
1	Caspase 9IBA 04/2009
1	Ligases (Synthetase)IBA 04/2009
1	Alkylating AgentsIBA 09/2007
1	Gemcitabine FDA Link 04/2007
1	DNA (Deoxyribonucleic Acid)IBA 12/2006
1	Cytarabine (Cytosar-U)FDA LinkGeneric 03/2006
1	7-hydroxystaurosporine (UCN 01)IBA 03/2006
1	Cyclin-Dependent Kinase 2IBA 09/2002
1	Cytostatic AgentsIBA 09/2002

Therapy/Procedure

14	Therapeutics 01/2023 - 09/2007
3	Drug Therapy (Chemotherapy) 04/2017 - 09/2007